SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-06-001905
Filing Date
2006-03-29
Accepted
2006-03-29 17:18:57
Documents
9
Period of Report
2006-03-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 IDERA PHARMACEUTICALS, INC. b60059ipe8vk.htm 8-K 32203
2 EX-4.1 AMENDMENT NO. 2 TO RIGHTS AGREEMENT b60059ipexv4w1.txt EX-4.1 6310
3 EX-10.1 COMMON STOCK PURCHASE AGREEMENT b60059ipexv10w1.txt EX-10.1 91595
4 EX-10.2 REGISTRATION RIGHTS AGREEMENT b60059ipexv10w2.txt EX-10.2 52682
5 EX-10.3 STOCK PURCHASE WARRANT b60059ipexv10w3.txt EX-10.3 38465
6 EX-10.4 COMMON STOCK PURCHASE AGREEMENT b60059ipexv10w4.txt EX-10.4 27412
7 EX-10.5 ENGAGEMENT LETTER b60059ipexv10w5.txt EX-10.5 13741
8 EX-10.6 REGISTRATION RIGHTS AGREEMENT b60059ipexv10w6.txt EX-10.6 35513
9 EX-10.7 WARRANT ISSUED TO BIOTECH SHARES LTD. b60059ipexv10w7.txt EX-10.7 30900
  Complete submission text file 0000950135-06-001905.txt   330489
Mailing Address 345 VASSAR STREET CAMBRIDGE MA 02139
Business Address 345 VASSAR STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 06719767
SIC: 2836 Biological Products, (No Diagnostic Substances)